Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

Gene therapy and gene editing are on the cutting edge of modern biotechnology. Gene therapies are used to correct genetic abnormalities by introducing genetic material at a cellular level and ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

HHS had argued that Vertex's plan to cover fertility services for some patients that took its gene therapy would violate anti-kickback and inducement laws.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Known as exagamglogene autotemcel (or ‘exa-cel’), clinical trials suggest this therapy can stop painful and unpredictable sickle cell crises. Furthermore, all patients who received exa-cel ...

Venture capital investor Vertex Ventures Japan (VVJ) announced the first close of its inaugural fund, Vertex Ventures Japan Fund I (VVJFI), which targets 10 billion yen (about $67 million) in total ...

If you’re on the fence about investing in Open Text Corporation, Vertex or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision ...

More than a year after Vertex Pharmaceuticals and CRISPR Therapeutics won FDA approval for the world’s first CRISPR edited therapy Casgevy® (“exa-cel” or exagamglogene autotemcel ...